Skip to main content

Advertisement

SpringerLink
Log in

Identification of characteristic and prognostic values of chromosome 1p abnormality by multi-gene fluorescence in situ hybridization in multiple myeloma

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Stewart AK, Fonseca R . Prognostic and therapeutic significance of myeloma genetics and gene expression profiling. J Clin Oncol 2005; 23: 6339–6344.

    Article  CAS  PubMed  Google Scholar 

  2. Chng WJ, Dispenzieri A, Chim CS, Fonseca R, Goldschmidt H, Lentzsch S et al. IMWG consensus on risk stratification in multiple myeloma. Leukemia 2014; 28: 269–277.

    Article  CAS  PubMed  Google Scholar 

  3. Shaughnessy JD Jr, Zhan F, Burington BE, Huang Y, Colla S, Hanamura I et al. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood 2007; 109: 2276–2284.

    Article  CAS  PubMed  Google Scholar 

  4. Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, Schinzel AC et al. Initial genome sequencing and analysis of multiple myeloma. Nature 2011; 471: 467–472.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Avet-Loiseau H, Li C, Magrangeas F, Gouraud W, Charbonnel C, Harousseau JL et al. Prognostic significance of copy-number alterations in multiple myeloma. J Clin Oncol 2009; 27: 4585–4590.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Qazilbash MH, Saliba RM, Ahmed B, Parikh G, Mendoza F, Ashraf N et al. Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant. Biol Blood Marrow Transplant 2007; 13: 1066–1072.

    Article  PubMed  Google Scholar 

  7. Leone PE, Walker BA, Jenner MW, Chiecchio L, Dagrada G, Protheroe RK et al. Deletions of CDKN2C in multiple myeloma: biological and clinical implications. Clin Cancer Res 2008; 14: 6033–6041.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Chng WJ, Gertz MA, Chung TH, Van Wier S, Keats JJ, Baker A et al. Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma. Leukemia 2010; 24: 833–842.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Boyd KD, Ross FM, Walker BA, Wardell CP, Tapper WJ, Chiecchio L et al. Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival. Clin Cancer Res 2011; 17: 7776–7784.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Hebraud B, Leleu X, Lauwers-Cances V, Roussel M, Caillot D, Marit G et al. Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients. Leukemia 2014; 28: 675–679.

    Article  CAS  PubMed  Google Scholar 

  11. Chang H, Ning Y, Qi X, Yeung J, Xu W . Chromosome 1p21 deletion is a novel prognostic marker in patients with multiplemyeloma. Br J Haematol 2007; 139: 51–54.

    Article  CAS  PubMed  Google Scholar 

  12. Li F, Xu Y, An G, Hu LP, Zhang YR, Li ZJ et al. The prognostic impact of 1p21 deletion on newly diagnosed multiple myeloma patients receiving thalidomide-based first-line treatment. Zhonghua Xue Ye Xue Za Zhi 2013; 34: 862–867.

    PubMed  Google Scholar 

  13. Walker BA, Leone PE, Chiecchio L, Dickens NJ, Jenner MW, Boyd KD et al. A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value. Blood 2010; 116: e56–e65.

    Article  CAS  PubMed  Google Scholar 

  14. Li F, Xu Y, Deng P, Yang Y, Sui W, Jin F et al. Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma. Oncotarget 2015; 6: 9434–9444.

    PubMed  PubMed Central  Google Scholar 

  15. Chang H, Qi X, Jiang A, Xu W, Young T, Reece D . 1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma. Bone Marrow Transplant 2010; 45: 117–121.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by grants from the National Natural Science Foundation of China (81172255, 81360353, 81400150), Science and Technology Infrastructure Program of Tianjin (12ZCDZSY17600), the Ministry of Science and Technology of China (2010DFB30270), Science Fund for Creative Research Groups (81421002), the Science and Technology Support Program of Jiangxi province (20141BBG70028), Science and Technology Cooperation Program (20151BDH80043) and Young Scientist Training Program (20153BCB23040) of Jiangxi Province. Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu).

Author information

Authors and Affiliations

  1. State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China

    F Li, L Hu, Y Xu, Z Li, S Yi, C Li, M Hao, K Ru, W Yuan, T Cheng & L Qiu

  2. Department of Hematology, The First Affiliated Hospital of Nanchang University, NanChang, China

    F Li

  3. Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA

    Z Gu & F Zhan

  4. Clinical Pathology Department of Karolinska Hospital, Karolinska Institute, Solna, Sweden

    A Zetterberg

Authors
  1. F Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Z Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Yi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Z Gu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M Hao
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. K Ru
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. F Zhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. A Zetterberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. W Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. T Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. L Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L Qiu.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, F., Hu, L., Xu, Y. et al. Identification of characteristic and prognostic values of chromosome 1p abnormality by multi-gene fluorescence in situ hybridization in multiple myeloma. Leukemia 30, 1197–1201 (2016). https://doi.org/10.1038/leu.2015.254

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2015.254

  • Springer Nature Limited

This article is cited by

Search

Navigation